【摘要】 急性呼吸窘迫综合征(ARDS)是一种起病急、病因复杂、病情重、病死率高的一种临床综合征。经过多年的研究发展,对ARDS的治疗已从无创正压通气(NIPPV)和气管插管机械通气(ETI-MV)等机械通气中获益,但是在获益的同时也发现了两者的劣势,警醒在机械通气带来效益的同时也要权衡两者的利弊,在对无创和有创机械通气准确把握及严密监测上下功夫。本研究分别从ARDS患者的NIPPV治疗、ETI-MV治疗、NIPPV切换为ETI-MV的影响因素和有创-无创序贯治疗等方面来进一步阐述。更多还原

【Abstract】 Acute respiratory distress syndrome(ARDS) is a clinical syndrome with acute onset,complex etiology, severe illness and high mortality. After years of research and development, the treatment of ARDS has benefited from mechanical ventilation such as noninvasive positive pressure ventilation(NIPPV) and endotracheal intubation-mechanical ventilation(ETI-MV). However, the disadvantages of both were found along with the benefits, which alerted us to weigh the advantages and disadvantages of both while enjoying the benefits of mechanical ventilation, and to make efforts in accurately grasping and closely monitoring non-invasive and invasive mechanical ventilation. This article further expounds the treatment of NIPPV, ETI-MV therapy, factors affecting the switching of NIPPV to ETI-MV and invasive-noninvasive sequential therapy in ARDS patients.更多还原